Medy-Tox KRX:086900KOSDAQ

메디톡스 · Korean news coverage and regulatory filings, organized.

Articles, 24h8
Articles, 7 days19
DART filings, 7 days0
Articles tracked19since Sep 11

In Q2 2026, Medy-Tox reported revenue of ₩68.7bn, up 11.4% year on year, and operating profit of ₩4.8bn. Medy-Tox (메디톡스) appeared in 19 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 11 articles. It was most often mentioned alongside Hugel, Daewoong Pharma and Daewoong.

Medy-Tox quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩68.7bn+11.4%₩4.8bn₩3.1bn
Q1 2026₩60.7bn-5.1%₩7.4bn₩7.9bn
Q4 2025 derived₩60.7bn+10.0%−₩3.7bn−₩3.1bn
Q3 2025₩61.0bn+13.3%₩8.9bn₩7.2bn
Q2 2025₩61.6bn-5.2%₩6.3bn₩8.2bn
Q1 2025₩64.0bn+17.2%₩5.5bn₩3.3bn
Q4 2024 derived₩55.2bn-18.9%₩947m₩2.4bn
Q3 2024₩53.9bn-8.2%₩6.0bn₩3.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Medy-Tox top stories 2 weeks, by number of outlets

  1. 1
  2. 2
    메디톡스, 해부학 기반 시술 교육 강화…‘MAP’ 워크숍 개최
    2 outlets · 2 articlesFirst report Sep 14 17:11 데일리한국
  3. 3
    메디톡스, 'MAP 아나토미 워크숍' 첫 개최
    2 outlets · 2 articlesFirst report Sep 15 08:14 핀포인트뉴스
  4. 4
    강연 넘어 해부 실습까지…메디톡스, ‘MAP’ 교육 범위 넓힌다
    1 outlets · 1 articlesFirst report Sep 14 17:16 한국면세뉴스
  5. 5
  6. 6
    "외국인 몰리는 홍대 공략"…메디톡스 '뉴라덤' 오프라인 영토 확장
    1 outlets · 1 articlesFirst report Sep 11 12:19 더페어뉴스

Latest Medy-Tox news Korean headlines